EDGEMOND JAMES sold UTHR
March 30, 2026 · Form 4 insider transaction
EDGEMOND JAMES sold 770 shares of United Therapeutics Corporation at $604.64 per share, a transaction worth $465.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
770
Price
$604.64
Total value
$465.6K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 30, 2026
Filing dateMarch 31, 2026
Shares owned after18,897
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.